Target intelligence / Profile preview

UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like 1 pseudogene 1 (B3GNTL1P1)

Target
B3GNTL1P1
Molecular classification
Other (Pseudogene)
01

Overview

UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like 1 pseudogene 1 (B3GNTL1P1, LOC105373314) is a human gene classified as a pseudogene, meaning it shares sequence similarity with a functional gene but does not itself encode a functional protein product[1][2][3][4][7]. There is no experimental evidence of molecular function, biological activity, involvement in disease, or relevance as a therapeutic target[1][2][3][4][7]. **Details and rationale:** - This entry is a **pseudogene**, not a functional gene, enzyme, receptor, or therapeutic target[1][3][4][7]. - Multiple authoritative sources (Alliance of Genome Resources, Monarch Initiative, GeneCards, HGNC) describe it as lacking function and merely being related by sequence to the B3GNT family[1][2][3][4][7]. - There are no known roles in disease, biological pathways, or evidence it can be targeted by drugs[1][2][3][4][7]. - It is not a receptor, enzyme, transporter, or other standard therapeutic target class. - The only possible aliases are its gene symbol (B3GNTL1P1) and locus identifier (LOC105373314)[2][3]. - Because it is not a functional molecule, is_target is false, and is_incorrect is true for therapeutic target context.

Other names
B3GNTL1P1LOC105373314

Beyond the preview

Go deeper on UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like 1 pseudogene 1 (B3GNTL1P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like 1 pseudogene 1 (B3GNTL1P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call